Mark Gaffney

Part of Lendlock Group Ltd., Integrated Aluminium Components Ltd. is a British company that manufactures and sells anodized parts and deep drawn pressing products. The company is based in Guilden Sutton, UK. The company was founded in 2007. Integrated Aluminium Components was acquired by Specialist Anodising Co. Ltd. from Recipharm AB on December 21, 2023.

Pharmaron Manufacturing Services (UK) Ltd. operates as pharmaceutical contract development and manufacturing company. It offers process research and development, analytical, clinical manufacturing and trial supply, and regulatory and support chain services. The company was founded in 2004 and is headquartered in Hemel Hempstead, the United Kingdom.

Part of Howden Joinery Group Plc, Sheridan Fabrications Ltd. is a British company that manufactures and distributes worktops. The company is based in Normanton, UK. The company was founded in 1995 by John Nathan Blackburn. Sheridan Fabrications was acquired by Howden Joinery Group Plc on February 15, 2022.

Vitec Production Solutions Ltd. distributes broadcast, movie, and pro video products. It offers bags, camera accessories, equipment rentals, lighting, mobile power, prompters, supports, robotic camera systems, wireless transmission systems, field monitors, and VR and AR camera tracking products. The company is headquartered in Richmond, the United Kingdom.

Part of Recipharm AB, Bespak Holdings Ltd. is a British company that functions as an investment holding company. The company is based in Hemel Hempstead, UK. Bespak Holdings was founded in 2000.

OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.

Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022.

Invest Europe is a Belgian company that operates as a private equity, venture capital and infrastructure investment company. The company is based in Brussels, Belgium.

Part of Pharmaron Beijing Co., Ltd., Aesica Queenborough Ltd. is a British pharmaceutical company founded in 2007. The company is based in Hemel Hempstead, UK. The company researches, develops, and manufactures pharmaceutical products.

Part of Recipharm AB, Aesica M2 Ltd. provides financial services. The company is based in Hemel Hempstead, UK.

IFM Cinque, Inc. is a biotechnology company. The company is headquartered in Boston, MA.

Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.

On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX.

JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE.

Complement Therapeutics Ltd. develops medicines that target the complement system. The British company was founded by Richard Unwin, Simon J. Clark, and Paul Bishop. The CEO is Rafiq Hasan.

Part of Recipharm AB, Aesica BC Ltd. is a British pharmaceutical company founded in 2011. The company is based in Hemel Hempstead, UK. The company engages in the manufacture of pharmaceutical products.

Part of Recipharm AB, Aesica M1 Ltd. functions as an investment holding British company. The company is based in Hemel Hempstead, UK and was founded in 2011.

Part of Recipharm AB, Consort Medical Finance Ltd. is an investment holding British company. The company is based in Hemel Hempstead, UK. Consort Medical Finance was founded in 2014.

Part of Recipharm AB, Consort Medical Finance 2010 Ltd. is an investment holding British company. The company is based in Hemel Hempstead, UK and was founded in 2010.

Part of Recipharm AB, Medical House Products Ltd. is a British company that manufactures medical and surgical equipment. The company is based in Hemel Hempstead, UK.

IFM Continua, Inc. engages in the provision of biotechnology services. The company is headquartered in Boston, MA.

IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA.

Allergan Ltd. provides eye care and specialty pharmaceutical products. It develops pharmaceutical products used for treatment of eye and skin care medications and neurological disorders. The firm develops products for glaucoma, dry eye, blepharospasm, cervical, dystonia, hemi-facial spasm, post-stroke spasticity and cerebral palsy. The company was founded in 1977 and is headquartered in Marlow, the United Kingdom.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020.

Part of Axovia Therapeutics Ltd., Axovia Therapeutics, Inc. is dedicated to developing disease-transformative therapies that target key aspects of ciliopathies. The American company is working to advance gene therapy programs that have already shown early promise in treating some of the most severe aspects of bbs, such as early onset blindness and neurometabolic disease. The company was founded by Philip Beales, Victor Hernandez, and Philip Beales has been the CEO since incorporation. Axovia Therapeutics was acquired by Alsa Management Services Ltd on September 19, 2023.

Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.